297 related articles for article (PubMed ID: 19887380)
1. TWEAK is a positive regulator of cardiomyocyte proliferation.
Novoyatleva T; Diehl F; van Amerongen MJ; Patra C; Ferrazzi F; Bellazzi R; Engel FB
Cardiovasc Res; 2010 Mar; 85(4):681-90. PubMed ID: 19887380
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats.
Mustonen E; Säkkinen H; Tokola H; Isopoussu E; Aro J; Leskinen H; Ruskoaho H; Rysä J
Acta Physiol (Oxf); 2010 May; 199(1):11-22. PubMed ID: 20082609
[TBL] [Abstract][Full Text] [Related]
3. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N
Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
Clin Exp Immunol; 2006 Dec; 146(3):540-9. PubMed ID: 17100776
[TBL] [Abstract][Full Text] [Related]
5. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
[TBL] [Abstract][Full Text] [Related]
6. E2F4 is required for cardiomyocyte proliferation.
van Amerongen MJ; Diehl F; Novoyatleva T; Patra C; Engel FB
Cardiovasc Res; 2010 Apr; 86(1):92-102. PubMed ID: 19955219
[TBL] [Abstract][Full Text] [Related]
7. FGF1-mediated cardiomyocyte cell cycle reentry depends on the interaction of FGFR-1 and Fn14.
Novoyatleva T; Sajjad A; Pogoryelov D; Patra C; Schermuly RT; Engel FB
FASEB J; 2014 Jun; 28(6):2492-503. PubMed ID: 24571920
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent effects of TWEAK/Fn14 receptor activation on neural progenitor cells.
Hamill CA; Michaelson JS; Hahm K; Burkly LC; Kessler JA
J Neurosci Res; 2007 Dec; 85(16):3535-44. PubMed ID: 17803219
[TBL] [Abstract][Full Text] [Related]
9. TWEAK induces liver progenitor cell proliferation.
Jakubowski A; Ambrose C; Parr M; Lincecum JM; Wang MZ; Zheng TS; Browning B; Michaelson JS; Baetscher M; Wang B; Bissell DM; Burkly LC
J Clin Invest; 2005 Sep; 115(9):2330-40. PubMed ID: 16110324
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-like weak inducer of apoptosis induces astrocyte proliferation through the activation of transforming-growth factor-α/epidermal growth factor receptor signaling pathway.
Rousselet E; Traver S; Monnet Y; Perrin A; Mandjee N; Hild A; Hirsch EC; Zheng TS; Hunot S
Mol Pharmacol; 2012 Nov; 82(5):948-57. PubMed ID: 22909796
[TBL] [Abstract][Full Text] [Related]
11. TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.
Xu H; Okamoto A; Ichikawa J; Ando T; Tasaka K; Masuyama K; Ogawa H; Yagita H; Okumura K; Nakao A
Biochem Biophys Res Commun; 2004 May; 318(2):422-7. PubMed ID: 15120617
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of cytokine TWEAK and its receptor Fn14 in pig (Sus scrofa).
Shui Y; Guan ZB; Zhang SQ
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):396-402. PubMed ID: 18817982
[TBL] [Abstract][Full Text] [Related]
13. Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase.
Tamamori-Adachi M; Takagi H; Hashimoto K; Goto K; Hidaka T; Koshimizu U; Yamada K; Goto I; Maejima Y; Isobe M; Nakayama KI; Inomata N; Kitajima S
Cardiovasc Res; 2008 Nov; 80(2):181-90. PubMed ID: 18596061
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
Joyce NC; Harris DL; Mello DM
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
[TBL] [Abstract][Full Text] [Related]
15. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.
Kamijo S; Nakajima A; Kamata K; Kurosawa H; Yagita H; Okumura K
Rheumatology (Oxford); 2008 Apr; 47(4):442-50. PubMed ID: 18310134
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy.
Busk PK; Hinrichsen R; Bartkova J; Hansen AH; Christoffersen TE; Bartek J; Haunsø S
Exp Cell Res; 2005 Mar; 304(1):149-61. PubMed ID: 15707582
[TBL] [Abstract][Full Text] [Related]
17. TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway.
Wang D; Fung JN; Tuo Y; Hu L; Chen C
Cancer Lett; 2010 Aug; 294(1):91-100. PubMed ID: 20189297
[TBL] [Abstract][Full Text] [Related]
18. TWEAK and Fn14: new molecular targets for cancer therapy?
Winkles JA; Tran NL; Berens ME
Cancer Lett; 2006 Apr; 235(1):11-7. PubMed ID: 15885893
[TBL] [Abstract][Full Text] [Related]
19. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
[TBL] [Abstract][Full Text] [Related]
20. Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis.
Mueller AM; Pedré X; Kleiter I; Hornberg M; Steinbrecher A; Giegerich G
J Neuroimmunol; 2005 Feb; 159(1-2):55-65. PubMed ID: 15652403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
